790 related articles for article (PubMed ID: 26998753)
1. In kidney transplant recipients with BK polyomavirus infection, early BK nephropathy, microvascular inflammation, and serum creatinine are risk factors for graft loss.
Mohamed M; Parajuli S; Muth B; Astor BC; Panzer SE; Mandelbrot D; Zhong W; Djamali A
Transpl Infect Dis; 2016 Jun; 18(3):361-71. PubMed ID: 26998753
[TBL] [Abstract][Full Text] [Related]
2. [BK virus infections in pediatric kidney transplant recipients].
Mutlu D; Sağlık I; Koyun M; Comak E; Mutlu E; Uslu Gökçeoğlu A; Cağla Doğan S; Dinçkan A; Akbaş SH; Akkaya B; Akman S; Süleymanlar G; Colak D
Mikrobiyol Bul; 2013 Jul; 47(3):461-71. PubMed ID: 23971923
[TBL] [Abstract][Full Text] [Related]
3. Factors and outcome in BK virus nephropathy in a Hispanic kidney transplant population.
Pérez-Torres D; Bertrán-Pasarell J; Santiago-Delpín E; González-Ramos M; Medina-Mangual S; Morales-Otero L; González-Caraballo Z
Transpl Infect Dis; 2010 Feb; 12(1):16-22. PubMed ID: 19804584
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Intravenous Immunoglobulin in the Treatment of Persistent BK Viremia and BK Virus Nephropathy in Renal Transplant Recipients.
Shah T; Vu D; Naraghi R; Campbell A; Min D
Clin Transpl; 2014; ():109-16. PubMed ID: 26281134
[TBL] [Abstract][Full Text] [Related]
5. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
6. BK virus nephropathy in renal transplant recipients in Kuwait: a preliminary report.
Nampoory MR; Johny KV; Pacsa A; Nair PM; Said T; Halim MA; Francis I; Samhan M; Mousawi M; Dalawi A; Szucs G; Al-Nakib W
Transplant Proc; 2005 Sep; 37(7):3048-50. PubMed ID: 16213300
[TBL] [Abstract][Full Text] [Related]
7. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
8. Results of repeat renal transplantation after graft loss from BK virus nephropathy.
Geetha D; Sozio SM; Ghanta M; Josephson M; Shapiro R; Dadhania D; Hariharan S
Transplantation; 2011 Oct; 92(7):781-6. PubMed ID: 21836535
[TBL] [Abstract][Full Text] [Related]
9. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
[TBL] [Abstract][Full Text] [Related]
10. BIOPSY-PROVEN BK VIRUS NEPHROPATHY WITHOUT DETECTABLE BK VIREMIA IN A ONE-YEAR POST-KIDNEY TRANSPLANT RECIPIENT.
Ruangkanchanasetr P; Pumchandh N; Satirapoj B; Termmathurapoj S; Pongthanapisith V
Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):657-61. PubMed ID: 26867385
[TBL] [Abstract][Full Text] [Related]
11. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous pancreas/kidney transplant recipients present with late-onset BK polyomavirus-associated nephropathy.
Schachtner T; Zaks M; Kahl A; Reinke P
Nephrol Dial Transplant; 2016 Jul; 31(7):1174-82. PubMed ID: 26758790
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients.
Vu D; Shah T; Ansari J; Naraghi R; Min D
Transplant Proc; 2015 Mar; 47(2):394-8. PubMed ID: 25769580
[TBL] [Abstract][Full Text] [Related]
14. Observations on the use of cidofovir for BK virus infection in renal transplantation.
Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
[TBL] [Abstract][Full Text] [Related]
15. Intensive polyoma virus nephropathy treatment as a preferable approach for graft surveillance.
Dheir H; Sahin S; Uyar M; Gurkan A; Turunc V; Kacar S; Bayirli Turan D; Basdemir G
Transplant Proc; 2011 Apr; 43(3):867-70. PubMed ID: 21486617
[TBL] [Abstract][Full Text] [Related]
16. BK virus nephritis after renal transplantation.
Hariharan S
Kidney Int; 2006 Feb; 69(4):655-62. PubMed ID: 16395271
[TBL] [Abstract][Full Text] [Related]
17. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of pre-transplant desensitization utilizing a plasmapheresis and low-dose intravenous immunoglobulin protocol on BK viremia in renal transplant recipients.
Gabardi S; Townsend K; Martin ST; Chandraker A
Transpl Infect Dis; 2013 Aug; 15(4):361-8. PubMed ID: 23647907
[TBL] [Abstract][Full Text] [Related]
19. Tacrolimus intrapatient variability in BK virus nephropathy and chronic calcineurin toxicity in kidney transplantation.
Turgut D; Sayin B; Soy EA; Topcu Dİ; Ozdemir BH; Haberal M
Saudi J Kidney Dis Transpl; 2021; 32(2):348-354. PubMed ID: 35017328
[TBL] [Abstract][Full Text] [Related]
20. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
